Trinity Financial Advisors LLC Buys New Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Trinity Financial Advisors LLC acquired a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXONFree Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 790 shares of the biotechnology company’s stock, valued at approximately $204,000.

Several other hedge funds have also recently bought and sold shares of the stock. Westfield Capital Management Co. LP boosted its holdings in Axon Enterprise by 184.3% during the third quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock worth $138,535,000 after buying an additional 451,350 shares during the last quarter. Vaughan Nelson Investment Management L.P. boosted its stake in shares of Axon Enterprise by 18.4% during the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 104,587 shares of the biotechnology company’s stock worth $27,019,000 after acquiring an additional 16,230 shares during the period. BKM Wealth Management LLC bought a new stake in Axon Enterprise in the 4th quarter valued at $32,000. Sumitomo Mitsui Trust Holdings Inc. boosted its stake in Axon Enterprise by 0.3% in the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 147,345 shares of the biotechnology company’s stock valued at $29,320,000 after purchasing an additional 495 shares during the period. Finally, International Assets Investment Management LLC bought a new stake in Axon Enterprise in the 4th quarter valued at $39,907,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON traded down $2.40 during mid-day trading on Wednesday, hitting $311.26. The company had a trading volume of 519,743 shares, compared to its average volume of 467,038. The company has a market capitalization of $23.49 billion, a price-to-earnings ratio of 135.74 and a beta of 0.93. Axon Enterprise, Inc. has a 1 year low of $175.37 and a 1 year high of $329.87. The company has a current ratio of 3.00, a quick ratio of 2.66 and a debt-to-equity ratio of 0.42. The stock’s 50-day moving average price is $306.01 and its 200-day moving average price is $263.59.

Axon Enterprise (NASDAQ:AXONGet Free Report) last posted its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 EPS for the quarter, topping the consensus estimate of $0.48 by $0.29. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. The business had revenue of $432.14 million during the quarter, compared to analysts’ expectations of $418.97 million. On average, sell-side analysts forecast that Axon Enterprise, Inc. will post 2.44 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on AXON shares. StockNews.com cut Axon Enterprise from a “buy” rating to a “hold” rating in a report on Thursday, March 14th. Barclays raised their target price on Axon Enterprise from $296.00 to $308.00 and gave the stock an “overweight” rating in a research note on Thursday, February 29th. William Blair reaffirmed an “outperform” rating on shares of Axon Enterprise in a research note on Wednesday, April 24th. Morgan Stanley raised their price objective on Axon Enterprise from $285.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday, April 26th. Finally, The Goldman Sachs Group raised their price objective on Axon Enterprise from $297.00 to $339.00 and gave the company a “buy” rating in a research note on Wednesday, February 28th. Two research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $323.09.

Check Out Our Latest Stock Analysis on AXON

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Articles

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.